Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraluminal Ureteric Injection of High Concentration Alkalinised Long-acting Local Anaesthetic and STeroid Post urEteroscopy: A Prospective Double Blinded Randomised Controlled Trial (LASTE Trial)

NCT03296189 is registered in ClinicalTrials.gov with The Adelaide and Meath Hospital, incorporating The National Children's Hospital as lead sponsor.

NCT NCT03296189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03296189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraluminal Ureteric Injection of High Concentration Alkalinised Long-acting Local Anaesthetic and STeroid Post urEteroscopy: A Prospective Double Blinded Randomised Controlled Trial (LASTE Trial)
Lead sponsor
The Adelaide and Meath Hospital, incorporating The National Children's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2018
Completion date
December 31, 2019
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative, ureter stone